Influence of Propylthiouracil and Methimazole Pre-treatment on the Outcome of Iodine-131 Therapy in Hyperthyroid Patients with Graves' Disease

被引：8
|
作者：
Shi, G-M [1 ]
Xu, Q. [2 ]
Zhu, C-Y [2 ]
Yang, Y-L [2 ]
机构：
[1] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Chemotherapy, Hangzhou 310003, Zhejiang, Peoples R China
[2] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Nucl Med, Hangzhou 310003, Zhejiang, Peoples R China
来源：
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH | 2009年 / 37卷 / 02期
关键词：
GRAVES' DISEASE; HYPERTHYROIDISM; PROPYLTHIOURACIL; METHIMAZOLE; (131)I THERAPY; RADIOACTIVE IODINE THERAPY; RANDOMIZED CLINICAL-TRIAL; RADIOIODINE THERAPY; ANTITHYROID DRUGS; CURE RATES; EFFICACY;
D O I：
10.1177/147323000903700235
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
There is ongoing controversy about potential differences in the influence of the anti-thyroid drugs propylthiouracil (PTU) and methimazole (MMI) on radioiodine treatment of Graves' hyperthyroidism. This retrospective study investigated the influence of PTU and MMI pre-treatment, individually or sequentially, on the outcome of iodine-131 ((131)I) therapy in 199 patients with Graves' disease who had been treated with (131)I for the first time and followed up at 3 and 6 months after treatment. Pre-treatment with PTU, or sequential PTU and MMI pretreatment, increased the failure rate of (131)I therapy and reduced the rate of hypothyroidism. MMI pre-treatment alone had no significant influence on the results of (131)I therapy. Logistic regression analyses indicated that PTU pre-treatment and having a thyroid gland of > 60 g were both significantly related to (131)I therapy failure.
引用
收藏
页码：576 / 582
页数：7
相关论文
共 50 条
  • [31] TREATMENT WITH PROPYLTHIOURACIL BEFORE RADIOACTIVE IODINE THERAPY IS ASSOCIATED WITH A HIGHER TREATMENT FAILURE RATE THAN THERAPY WITH RADIOACTIVE IODINE ALONE IN GRAVES-DISEASE
    TUTTLE, RM
    PATIENCE, T
    BUDD, S
    THYROID, 1995, 5 (04) : 243 - 247
  • [32] Comparison of Fixed 10 mCi and 15 mCi Iodine-131 Doses for the Treatment of Graves' Disease: 11 Year Study
    Dede, Fuat
    Ones, Tunc
    Candemir, Sinem
    Novruzov, Fuad
    Gungor, Serkan
    Aras, Mustafa
    Ozguven, Salih
    Inanir, Sabahat
    Erdil, Tanju Yusuf
    Turoglu, Halil Turgut
    MARMARA MEDICAL JOURNAL, 2011, 24 (01): : 26 - 30
  • [33] Predictive Value of a Thyroid-Absorbed Dose with a Shorter Effective Half-Life on Efficacy in Graves Disease Patients Receiving Iodine-131 Therapy
    Yu, Feng
    Zhang, Ruiguo
    Zhang, Guizhi
    Meng, Zhaowei
    Liu, Xiaohua
    He, Yajing
    Tan, Jian
    Wang, Renfei
    MEDICAL SCIENCE MONITOR, 2021, 27
  • [34] Effect of methimazole treatment for 2 years on circulating IL-4, IgE, TBII, and TSAb in patients with hyperthyroid Graves' disease
    Yamada, Takashi
    Komiya, Ichiro
    Miyahara, Yasuhiro
    Komatsu, Mitsuhiro
    Shima, Ikuno
    Inazawa, Takeshi
    Aizawa, Toru
    ENDOCRINE JOURNAL, 2006, 53 (06) : 783 - 788
  • [35] TREATMENT OF THYROTOXICOSIS WITH IODINE-125 - RESULTS IN 93 PATIENTS 3 TO 5 YEARS AFTER TREATMENT, AND COMPARISON WITH IODINE-131 THERAPY
    GLANZMANN, C
    HORST, W
    STRAHLENTHERAPIE, 1979, 155 (01) : 1 - 5
  • [36] The influence of non-radioactive iodine (I-127) on the outcome of radioiodine (I-131) therapy in patients with Graves' disease and toxic nodular goitre
    Rogowski, Franciszek
    Abdelrazek, Saeid
    Szumowski, Piotr
    Zonenberg, Anna
    Parfienczyk, Adam
    Sawicka, Agnieszka
    NUCLEAR MEDICINE REVIEW, 2011, 14 (01) : 9 - 15
  • [37] THYROTROPIN RECEPTOR ANTIBODY ACTIVITIES SIGNIFICANTLY CORRELATE WITH THE OUTCOME OF RADIOIODINE (I-131) THERAPY FOR HYPERTHYROID GRAVES-DISEASE
    KAISE, K
    KAISE, N
    YOSHIDA, K
    FUKAZAWA, H
    MORI, K
    YAMAMOTO, M
    SAKURADA, T
    SAITO, S
    YOSHINAGA, K
    ENDOCRINOLOGIA JAPONICA, 1991, 38 (04): : 429 - 433
  • [38] Prognostic predictors of treatment outcome of hyperthyroid patients receiving Radioactive Iodine (RAI) therapy.
    Ab Aziz, A.
    Zainudin, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S500 - S500
  • [39] Comparison of methimazole and propylthiouracil in the management of children and adolescents with Graves' disease: efficacy and adverse reactions during initial treatment and long-term outcome
    Sato, Hirokazu
    Minagawa, Masanori
    Sasaki, Nozomu
    Sugihara, Shigetaka
    Kazukawa, Itsuro
    Minamitani, Kanshi
    Wataki, Kunio
    Konda, Susumu
    Inomata, Hiroaki
    Sanayama, Kazunori
    Kohno, Yoichi
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2011, 24 (5-6): : 257 - 263
  • [40] Predictive factors for the outcomes of Graves' disease patients with radioactive iodine (131I) treatment
    Xing, Yu-Zhuo
    Zhang, Kun
    Jin, Gang
    BIOSCIENCE REPORTS, 2020, 40
12345